GLP-1 Medications and Mental Health: An Australian Guide

GLP-1 medications are widely recognised for their role in weight management and type 2 diabetes treatment. However, emerging research is now exploring a new and unexpected area: their potential impact on mental health.

Recent studies have suggested these medications may help reduce symptoms of anxiety and depression in some patients. This has generated both interest and confusion, particularly among Australians considering these treatments for weight loss or metabolic conditions.

At Qoctor, with over a decade of telehealth experience and hundreds of thousands of consultations, we’ve seen firsthand how closely physical and mental health are connected. Understanding the full picture of any medication — including its psychological effects — is essential for safe and informed decision-making.

This article explains what current research says about GLP-1 medications and mental health, clarifies common misconceptions, and outlines what Australians should consider before starting treatment.

Can GLP-1 Medications Improve Mental Health?

A recent study published in the Lancet Medical Journal suggests that GLP-1 receptor agonists may have a positive effect on mental health outcomes in some individuals.

Recent large-scale research and clinical analysis have observed:

• Reduced symptoms of depression in patients using GLP-1 medications

• Lower rates of anxiety-related conditions

• Improvements in overall psychological wellbeing

These effects may be explained by several mechanisms:

1. Brain Chemistry and Appetite Regulation

GLP-1 receptors are present not only in the gut but also in the brain. These medications may influence neurotransmitters involved in mood regulation.

2. Reduced Inflammation

Chronic inflammation is linked to both obesity and depression. GLP-1 medications may reduce systemic inflammation, which could indirectly support mental wellbeing.

3. Weight Loss and Psychological Impact

Sustainable weight loss can improve confidence, physical function, and quality of life — all of which are associated with better mental health.

However, it’s important to emphasise:
These medications are not approved as treatments for mental health conditions in Australia.

Their psychological effects are considered secondary and still under investigation.

Practical Implications for Patients in Australia

If you’re considering GLP-1 medications, it’s important to understand how mental health fits into the broader treatment plan.

What Patients Should Know

• Mental health improvements are not guaranteed

• Effects vary significantly between individuals

• Some patients may experience no change in mood

• Monitoring is important, especially if you have existing mental health conditions

• In fact, some months ago the TGA issued a safety warning that some people may experience a deterioration in their mental health on these medications- if this occurs it is crucial to speak to your doctor or pharmacist as soon as possible.

What Doctors Assess

Australian doctors will typically consider:

• Weight-related health risks

• Medical and mental health history

• Current medications

• Lifestyle and social factors

This ensures safe, appropriate prescribing.

Risks of Oversimplified Services

Be cautious of services that:

• Promise mental health improvements

• Offer treatment without proper consultation

• Ignore psychological history

 

Compliance & Clinical Integrity in Telehealth Prescribing

In Australia, prescribing GLP-1 medications — particularly via telehealth — must follow strict standards.

Key Requirements

• AHPRA Registration- All doctors must be registered and meet national standards.
• Real-Time Consultation- A proper consultation (video or phone) is required — not just an online form.
• Clinical Discretion- Doctors must assess suitability of treatment, risks vs benefits and long-term health outcomes
• Documentation & Verification- Accurate records must include diagnosis, treatment plan, and follow-up.

Why This Matters

GLP-1 medications can be highly effective — but only when prescribed responsibly.

Without proper oversight, risks include:

• Side effects

• Inappropriate use

• Missed underlying health issues

Final Thoughts

GLP-1 medications are an important development in managing weight and metabolic health. The possibility that they may also support mental wellbeing is promising, but still being studied.

While some individuals may experience improvements or changes in mood, these medications are not designed to treat mental health conditions. Proper care requires a balanced, evidence-based approach that considers both physical and psychological health.

For Australians, the safest approach is to seek guidance from qualified doctors who can assess your individual situation and provide appropriate advice. And if you need further support or advice regarding your mental health, a GP can discuss your options with you.

Ultimately, informed decisions and proper medical guidance remain essential.